GlassScriptPhysician profile
Jeffrey Moy
NPI 1942632856
$1,561.26
in general payments reported to CMS, 2019-2025
21 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $312 · 2021: $247 · 2022: $328 · 2023: $69.14 · 2024: $185 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $350.26 | 2021-2024 | Puraply |
| Smith+Nephew, INC. | $286.22 | 2019-2025 | Collagenase Santyl |
| Paragon 28, INC. | $166.79 | 2020 | |
| Zimmer Biomet Holdings, INC. | $136.35 | 2019 | |
| Tactile Systems Technology INC | $129.00 | 2020-2022 | |
| Musculoskeletal Transplant Foundation INC. | $62.78 | 2022 | |
| Verrica Pharmaceuticals INC. | $59.34 | 2024-2025 | Ycanth |
| Cranial Technologies, INC | $52.47 | 2024-2025 | Doc Band |
| Orthofix Medical, INC. | $48.71 | 2022 | |
| Stryker Corporation | $42.27 | 2020 | |
| Allergan, INC. | $34.96 | 2019 | |
| Abbvie INC. | $28.98 | 2021 | |
| Hartmann USA, INC. | $25.39 | 2021 | |
| Resmed Corp | $19.10 | 2022 | |
| Medline Industries LP | $18.94 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $18.64 | 2025 | Myfembree |
| Paratek Pharmaceuticals, INC. | $17.99 | 2020 | |
| Hologic Sales and Service, LLC | $17.55 | 2020 | |
| Nevro Corp. | $17.39 | 2022 | |
| Melinta Therapeutics, LLC | $14.19 | 2020 | |
| Lilly USA, LLC | $13.94 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Moy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.